Gut microbiota changes after starting Compleat Paediatric Nature Mix in kids on exclusive enteral nutrition
Official title: Observational, Single-center Study Evaluating Changes in the Intestinal Microbiota of Children Exclusively Fed Via Gastrostomy When Switching to the Enteral Nutrition Formula Compleat® Paediatric Nature Mix.
Run by Establishment for Children and Adolescents in the Nantes Region · NCT07816536 · Data updated 2026-11-12
This study tests whether a food-based pediatric enteral formula changes gut bacteria in children who rely on tube feeding for nutrition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Year to 16 Years |
| Sex | All |
| Enrollment | 8 (estimated) |
| Sponsor | Establishment for Children and Adolescents in the Nantes Region Academic / other |
| Locations | 1 site (Nantes) |
| Status | Recruiting |
| Started | March 4, 2026 |
| Main results expected | February 2027 |
| Study ends | May 2027 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07816536 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 1 to 16 years who require exclusive enteral nutrition and are managed at the participating Nantes center, whose guardians understand French and consent to participation.
✕Probably not a fit
Children who do not show gut microbiota changes or tolerate the formula poorly may not experience the anticipated benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center observational study evaluating fecal microbiota changes in children aged 1–16 years who require exclusive enteral nutrition and are switched to Compleat Paediatric Nature Mix. Researchers will use shotgun metagenomics to analyze stool samples and will also monitor digestive tolerance, bowel habits, sleep quality, feeding rate, and related medications over six months. The study hypothesizes that fibers in the food-based formula promote beneficial gut bacteria and short-chain fatty acid production, potentially improving digestive tolerance. The work is conducted at a single Nantes pediatric center in collaboration with PhAN laboratory, with inclusion based on routine clinical care and French-language understanding. There is no randomization or control group as the design is observational and non-interventional.
Why it matters
Potential benefit: If successful, the approach could improve digestive tolerance and gut health for children requiring exclusive enteral nutrition.
How similar studies have gone: Prior work in blended or food-based enteral nutrition has suggested potential tolerance benefits, but this specific pediatric microbiota-focused evaluation is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged 1 to 16 years * Exclusive enteral nutrition * Followed as part of routine care at the participating pediatric center * Legal guardians and caregivers able to understand French * Covered by the French social security system or equivalent * Documented non-opposition from legal representatives and, when possible, from the child Exclusion Criteria: * Oral feeding or non-exclusive enteral nutrition * Use of oral nutritional supplements * Requirement for hypercaloric (\>1.2 kcal/mL) or hypocaloric (\<1 kcal/mL) enteral formulas * Acute clinical decompensation within one month prior to inclusion * Acute viral or bacterial gastroenteritis within one month prior to inclusion * Antibiotic or probiotic use within three months prior to inclusion
Where it's running
-
ESEAN - APF France Handicap
Nantes, France Recruiting
Study contacts
- Study coordinator: Guy LETELLIER, PH
- Email: guy.letellier@apf.asso.fr
- Phone: +33240343884
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biolizin to improve functional poor appetite in toddlers 6–36 months
This trial will test whether a zinc syrup (Biolizin), given with caregiver responsive-feeding counseling, helps children 6–36 months old who have persistent poor appetite without a medical cause.
-
Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa
In women with bulimia nervosa, this study tests whether real-time brain feedback during eating, paired with a 4-week text-message program, can help improve self-control and reduce symptoms.
-
Insulin delivery technology and eating behaviours in people with type 1 diabetes
This project will test whether automated insulin delivery systems change eating behaviours and make carbohydrate counting easier for people aged 12 and older who have type 1 diabetes in Canada.
-
Using deep transcranial magnetic stimulation to enhance therapy for anorexia nervosa
This study is testing if adding a special brain stimulation treatment to therapy can help people with anorexia nervosa feel better and improve their recovery.
-
Evaluating a new therapy for adolescents at risk of severe eating disorders
This study is testing a new therapy called Radically Open Dialectical Behavior Therapy to see if it can help teenagers aged 14-19 who are at risk of serious eating disorders feel better and manage their emotions.
-
Comparing two therapies for adolescents with eating disorders
This study is testing which treatment, enhanced cognitive behavior therapy or family-based therapy, works better for teenagers with eating disorders to help them feel better and improve their lives.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.